TUDOR INVESTMENT CORP ET AL - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 119 filers reported holding KARYOPHARM THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.17 and the average weighting 0.1%.

Quarter-by-quarter ownership
TUDOR INVESTMENT CORP ET AL ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$588
+44.5%
151,235
+26.3%
0.01%
+12.5%
Q4 2022$407
-99.9%
119,755
+99.4%
0.01%
+14.3%
Q3 2022$328,000
+33.3%
60,064
+10.2%
0.01%
+16.7%
Q2 2022$246,000
-81.7%
54,513
-73.9%
0.01%
-72.7%
Q4 2021$1,341,000
+19.4%
208,526
+8.1%
0.02%
+22.2%
Q3 2021$1,123,000
+34.7%
192,931
+138.9%
0.02%
+12.5%
Q2 2021$834,000
-4.9%
80,772
-3.1%
0.02%
-11.1%
Q1 2021$877,000
+85.4%
83,372
+157.2%
0.02%
-14.3%
Q3 2020$473,000
-54.2%
32,418
-39.8%
0.02%
-54.3%
Q4 2019$1,032,000
+533.1%
53,859
+343.0%
0.05%
+820.0%
Q1 2018$163,000
-25.6%
12,157
-46.8%
0.01%
-16.7%
Q4 2017$219,000
+10.6%
22,836
+26.3%
0.01%
+20.0%
Q3 2017$198,000
+45.6%
18,075
+19.9%
0.01%
+25.0%
Q2 2017$136,000
+24.8%
15,078
+29.7%
0.00%
+33.3%
Q4 2016$109,000
-31.4%
11,624
-28.7%
0.00%
-25.0%
Q3 2016$159,000
-77.2%
16,313
+8.8%
0.00%
-85.2%
Q2 2014$698,00015,0000.03%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Consonance Capital Management LP 7,180,700$137,941,00010.27%
Palo Alto Investors LP 4,299,901$82,601,0006.92%
Fairmount Funds Management LLC 562,351$10,803,0006.55%
Avoro Capital Advisors LLC 7,000,000$134,470,0004.54%
Pinz Capital Management, LP 8,820$1,694,0004.44%
Birchview Capital, LP 148,000$2,843,0002.52%
Elk Creek Partners, LLC 699,951$13,446,0002.31%
Parkman Healthcare Partners LLC 215,802$4,146,0001.92%
EAM Global Investors LLC 136,402$2,620,0001.53%
SPHERA FUNDS MANAGEMENT LTD. 550,000$10,566,0001.32%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders